Warren Fiskus
23PUBLICATIONS
73CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (23)
Sort by Publication Date:
|Feb 24, 2026
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.Warren Fiskus, Christopher P Mill, Ghayas C Issa
|Jan 19, 2026
Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML.Warren Fiskus, Christopher P Mill, Jessica Piel
|Dec 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.Christine E Birdwell, Warren Fiskus, Christopher P Mill
|Aug 19, 2025
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase.Warren Fiskus, Lucia Masarova, Christopher P Mill
|Mar 16, 2025
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations.Warren Fiskus, Christopher P Mill, Jessica Piel
|Nov 19, 2024
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.Warren Fiskus, Christopher P Mill, Prithviraj Bose
Pageof 4
Frequent Collaborators
17 joint publications
Courtney DiNardo
17 joint publications
Kapil N Bhalla
15 joint publications
Naval G Daver
14 joint publications
Tapan M Kadia
12 joint publications
Christopher P Mill
10 joint publications
Sanam Loghavi
9 joint publications
Koji Sasaki
9 joint publications
Joseph D Khoury
9 joint publications
Koichi Takahashi
8 joint publications
Kaberi Das
